ARCHIVES

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

This article is from The Cancer Letter archive.

Vol. 02 No. 41 | October 8, 1976

Download PDF Visit The Full Archive

Related Articles

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

AACR To Screen Attendees From SARS-Affected Areas.

June 20, 2003

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

ACS Asks Reagan To Back Stronger Cigarette Warning

April 2, 1982